Moreover, since IRAK1/4 inhibitors induced apoptosis in human CML LSCs in the absence of T-cell immunity, it is likely that the inhibitors themselves also directly induce apoptosis in CML LSCs. The gene discussed is IRAK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.